GORMAN KEVIN CHARLES bought NBIX
January 8, 2024 · Form 4 insider transaction
GORMAN KEVIN CHARLES bought 105,835 shares of Neurocrine Biosciences, Inc. at $19.59 per share, a transaction worth $2.07M. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
105,835
Price
$19.59
Total value
$2.07M
InsiderGORMAN KEVIN CHARLES
Role—
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateJanuary 8, 2024
Filing dateJanuary 10, 2024
Shares owned after605,589
OwnershipDirect
10b5-1 planNo
AmendedNo